Draft Patents (Amendment), Rules, 2023
The Ministry of Commerce and Industry, under the Department for Promotion of Industry and Internal Trade, has introduced draft amendments to the Patents Rules, 2003. These drafts detail various changes
Patents
-
Brazil cooks up transgenic bean
Approval draws criticism over transparency and safety tests.
-
A win-win solution?: A critical analysis of tiered pricing to improve access to medicines in developing countries
Tiered pricing - the concept of selling drugs and vaccines in developing countries at prices systematically lower than in industrialized countries - has received widespread support from industry, policymakers,
-
Draft National Pharmaceuticals Pricing Policy, 2011
The National Pharmaceuticals Pricing Policy 2011 presently seeks to limit itself to the central objective of promulgating the principles for pricing of Essential Drugs as laid down in the “National List
-
'Patent trolls' target biotechnology firms
The biotechnology industry has had its share of woes, but so far 'patent trolls' have not numbered among them. These companies, which profit by legally enforcing patents they own rather than developing
-
Monsanto Wins Lawsuit Against Indiana Soybean Farmer
Monsanto Co., the world's largest seed company, has prevailed in another lawsuit against a U.S. farmer, earning a ruling from a federal appeals court that protects Monsanto's interests even when its patented
-
NCL scientist gets OPPI young scientist award
A scientist from city-based National Chemical Laboratory (NCL), Dattatraya H Dethe, has been selected for the Organisation of Pharmaceutical Producers of India (OPPI) Young Scientist award 2011 for his
-
Patent medicine
A simplification of the US patent system is good news for inventors, but could have gone further. (Editorial)
-
MoEF to look into CPCB chief pushing own device
New Delhi: Reacting to a TOI report on the conflict of interest of Central Pollution Control Board chairman, environment and forests minister Jayanthi Natarajan has said she will inquire into the facts.
-
Pfizer, Dr Reddy’s Settle Patent Suit over Lipitor
Pfizer Inc and Dr Reddy’s Laboratories have settled a patent infringement suit related to the Indian drug maker’s launch of a generic version of the blockbuster drug, Lipitor, in the US. Pfizer’s Lipitor
-
Pollution board chief cashed in on own patent
New Delhi: Chairman of the Central Pollution Control Board S P Gautam sold a patent he held privately on a technology to the apex authority on a revenue sharing basis and then passed a directive in his